Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Bronchus and Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Early research (Phase 1)WithdrawnNCT03920839
What this trial is testing

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Who this might be right for
Advanced and/or Metastatic Solid TumorsStage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung CancerAdvanced/Metastatic Unresectable Malignant Pleural Mesothelioma
Incyte Corporation
Early research (Phase 1)Study completedNCT03590054
What this trial is testing

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Stage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more
Rahul Aggarwal 35
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Not applicableStudy completedNCT01802203
What this trial is testing

TrūFreeze® Spray Cryotherapy Patient Registry

Who this might be right for
Barrett EsophagusEsophageal DysplasiaEsophageal Neoplasm+3 more
US Endoscopy Group Inc. 275
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971501
What this trial is testing

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 5
Not applicableStudy completedNCT02378337
What this trial is testing

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

Who this might be right for
Malignant Neoplasm of BreastHodgkin DiseaseNon-Hodgkin Lymphoma, Follicular (Nodular)+5 more
Hospital Sao Rafael 335
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Early research (Phase 1)Looking for participantsNCT06171750
What this trial is testing

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more
Ankyra Therapeutics, Inc 97
Early research (Phase 1)Study completedNCT02571036
What this trial is testing

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Who this might be right for
Gastrointestinal Stromal TumorsAdvanced Systemic MastocytosisAdvanced Cancers
Deciphera Pharmaceuticals, LLC 282
Testing effectiveness (Phase 2)Looking for participantsNCT06090266
What this trial is testing

OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+4 more
OncoResponse, Inc. 168
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Early research (Phase 1)Study completedNCT01999985
What this trial is testing

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute 25
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Testing effectiveness (Phase 2)Ended earlyNCT00402896
What this trial is testing

Malignant Pleural Effusion With ZD6474

Who this might be right for
Lung CancerPleural Effusion
M.D. Anderson Cancer Center 28
Next Page